Table 2.
Anthropometric, blood-derived, and dietary intake data (n = 10)
| Parameter | Baseline | Month 3 | P-value |
|---|---|---|---|
| Anthropometric measures | |||
| Weight, kg | 76.5 (17.4) | 74.7 (16.2) | .81 |
| BMI, kg/m2 | 27.7 (7.5) | 26.9 (6.8) | .81 |
| Body fat, % | 38.6 (11.5) | 38.2 (11.3) | .94 |
| Lean body mass, kg | 43.5 (7.6) | 42.8 (8.6) | .85 |
| Bone mass, kg | 2.7 (0.7) | 2.7 (0.7) | .98 |
| Lipid status | |||
| Total cholesterol, mg/dL | 173.0 (27.5) | 194.4 (36.3) | .16 |
| LDL, mg/dL | 102.1 (18.7) | 117.4 (25.4) | .14 |
| HDL, mg/dL | 55.4 (9.2) | 58.2 (8.6) | .49 |
| Serum biomarkers | |||
| AST, U/L | 21.1 (5.2) | 24.5 (7.0) | .24 |
| ALT, U/L | 15.7 (6.5) | 18.9 (8.1) | .34 |
| Alkaline phosphatase, U/L | 62.6 (21.3) | 55.8 (19.5) | .48 |
| Calcium, mg/dL | 9.4 (0.4) | 9.5 (0.3) | .71 |
| Chloride, mEq/L | 104.1 (1.3) | 105.4 (2.2) | .12 |
| Potassium, mEq/L | 4.0 (0.3) | 4.1 (0.2) | .47 |
| Sodium, mEq/L | 137.2 (1.8) | 137.9 (1.9) | .41 |
| BUN, mg/dL | 20.9 (4.3) | 20.1 (6.1) | .74 |
| Creatinine, mg/dL | 1.0 (0.2) | 1.1 (0.3) | .58 |
| Metabolic status | |||
| Insulin, μU/mL | 5.1 (2.2) | 5.0 (2.2) | .94 |
| Glucose, mg/dL | 92.6 (5.6) | 95.8 (10.0) | .40 |
| HOMA2-IR | 0.7 (0.3) | 0.7 (0.3) | .97 |
| Beta, % | 67.8 (22.1) | 62.3 (19.0) | .56 |
| Sensitivity, % | 169.6 (51.0) | 182.3 (86.4) | .70 |
| Dietary intake | |||
| Energy (kcal) | 1950.7 (450.6) | 2002.8 (660.7) | .80 |
| Fat, g | 90.6 (23.5) | 166.7 (60.0) | <.001∗ |
| Carbohydrate, g | 209.8 (80.3) | 46.0 (26.9) | <.001∗ |
| Protein, g | 81.3 (21.1) | 90.0 (28.2) | .34 |
Abbreviations: BMI, body mass index; LDL, low-density lipoprotein; HDL, high-density lipoprotein; AST, aspartate aminotransferase; ALT, alanine aminotransferase; BUN, blood urea nitrogen; HOMA2-IR, homeostatic model assessment 2-insulin resistance; SD, standard deviation.
NOTE. Values are Mean (SD).
∗
Significant difference between time points (P ≤ .05).